erythromycin has been researched along with Myotonic Dystrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Eltahir, MK; Hattori, S; Kimura, T; Mochizuki, H; Nagano, S; Nakamori, M | 1 |
Andersson, S; Danielsson, A; Hellström, PM; Rönnblom, A | 1 |
2 other study(ies) available for erythromycin and Myotonic Dystrophy
Article | Year |
---|---|
Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1.
Topics: Animals; Erythromycin; Humans; Myotonic Dystrophy; Quality of Life; Reproducibility of Results; RNA; RNA-Binding Proteins | 2022 |
Gastric emptying in myotonic dystrophy.
Topics: Adult; Case-Control Studies; Diarrhea; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Male; Middle Aged; Myotonic Dystrophy; Statistics, Nonparametric; Technetium | 2002 |